Seattle, WA -- (SBWIRE) -- 11/06/2019 -- Narcotics analgesics are opioids medications that have a similar function to endorphins, elements produced by the body to control pain. Basically, opioids are used for treating acute pain associated with surgery and other medical procedure and also for control persistent an advance pain. Moreover, they are also used as anesthesia, cough syrups, and to treat diarrhea but they are offered via prescription only since they are addictive and may result in a fatal overdose, thus the use of narcotics analgesics is strictly regulated by the governments.
Growing research and development activities for narcotics drugs is expected to propel market growth over the forecast period. For instance, a phase III clinical study by Loma Linda University is undergoing drug Narco. The objective of the study is to evaluate patient pain levels in the immediate post-operative period and quantify pain medication usage in patients who undergo outpatient Ear, Nose, and Throat (ENT) surgeries. The study was started on February 2018 and is estimated to complete in January 2019.
Get PDF Brochure of Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/2308
Furthermore, Temple University along with AstraZeneca is undergoing a clinical phase II study to assess the effect of opioids on esophageal motility. The study found that chronic opioid users are suffering from esophageal motor dysfunctioning. This study will explore the safety and tolerability of MOVANTIK (Naloxegol) and is expected to improve opioid-induced esophageal motility disorders. The study was started in January 2017 and is expected to complete in January 2020.
Shortages of narcotics analgesics medications are likely to impact the market growth negatively. For instance, according to the Drug Enforcement Administration (DEA) of U.S. February 2018, hospitals and other healthcare providers in the U.S. are currently facing critical shortages of a number of injectable opioid medications, including morphine, hydromorphone, and fentanyl. Injectable opioids are critical to treat the pain needs of patients undergoing interventional procedures such as cardiac catheterization and surgeries. A diminished supply of these critical drugs can lead to less efficient pain control for patients since opioid analgesics are highly potent in pain control.
Get Request Sample from Industry Experts @ https://www.coherentmarketinsights.com/insight/request-sample/2308
Geographically, North America is likely to dominate the overall global narcotics analgesics market and this can be attributed to rising misuse of opioid analgesics. For instance, according to the Federal Government of the U.S., in 2015, 8.5 million people i.e. 3% of the population of U.S. misused opioid painkillers in 2015, and 2.5 million were addicted to either painkillers or heroin in 2015. Moreover, More than 33,000 people died from overdoses of opioid drugs in 2015.
Europe region is also expected to perceive immense growth in the global narcotics analgesics market since few countries in the European Union are misusing prescription opioid analgesics as normal pain killers which is not advisable as these are habit forming drugs. For instance, according to the BMC Psychiatry journal in August 2016, Spain had the highest use of opioids for non-medical purposes, and Great Britain had the second-highest opioid users.
The key players operating in narcotics analgesics market include Pfizer Inc., Teva Pharmaceuticals, Allergan plc, BioDelivery Sciences International, Inc., Endo Pharmaceuticals, Inc., Akron, Inc., UCB, Inc., Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, and Janssen Pharmaceuticals, Inc.
Inquire about Discount on this Report @ https://www.coherentmarketinsights.com/insight/request-discount/2308
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.